Motley Fool Australia

ResApp Health Ltd (ASX: RAP) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $43.21 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 758.12 million
Earnings per share -0.012
Dividend per share N/A
Year To Date Return -30.59%
Earnings Yield N/A
Franking N/A

ResApp Health (ASX: RAP) Latest News

resmed

The ResApp (ASX:RAP) share price is soaring 10% today. Here’s why.

More »

share price down

Why Computershare, Newcrest, Prospa, & ResApp are sinking lower

More »

Red arrow downward chart

Why the ResApp share price crashed 67% lower today

More »

Health technology shares

ResApp share price flat following news on prototype devices

More »

business share price

Why ResApp, SKY Network, Telstra, & Volpara shares are storming higher

More »

asx healthcare shares

ResApp share price races 13% higher on telehealth deal

More »

handshake agreement

ResApp share price races 7% higher on Sanofi agreement

More »

share price higher

ResApp and these ASX shares just raced to 52-week highs

More »

About ResApp Health Ltd (ASX: RAP)

ResApp Health Ltd is engaged in development and commercialization of the ResApp technology for the purpose of providing health care solutions for respiratory disease. The company's solutions are designed to be easily integrated into existing telehealth solutions and it is working on apps to provide respiratory disease diagnosis and management directly to consumers and healthcare providers. Its products are for Acute Disease Diagnosis; for Chronic Disease Management; and for Sleep Apnoea.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
25 Feb 2021 $0.06 $0.00 0.00% 4,196,758 $0.05 $0.06 $0.05
24 Feb 2021 $0.06 $0.00 0.00% 6,099,749 $0.06 $0.06 $0.05
23 Feb 2021 $0.06 $0.00 0.00% 836,676 $0.06 $0.06 $0.06
22 Feb 2021 $0.06 $0.00 0.00% 5,226,063 $0.06 $0.06 $0.06
19 Feb 2021 $0.06 $0.00 0.00% 3,820,160 $0.06 $0.06 $0.06
18 Feb 2021 $0.06 $0.00 0.00% 1,821,946 $0.07 $0.07 $0.06
17 Feb 2021 $0.07 $0.00 0.00% 2,089,282 $0.07 $0.07 $0.07
16 Feb 2021 $0.07 $0.00 0.00% 1,615,776 $0.07 $0.07 $0.07
15 Feb 2021 $0.07 $0.00 0.00% 1,265,860 $0.07 $0.07 $0.07
12 Feb 2021 $0.07 $0.00 0.00% 1,348,003 $0.07 $0.07 $0.07
11 Feb 2021 $0.07 $0.00 0.00% 2,109,182 $0.07 $0.07 $0.07
10 Feb 2021 $0.07 $0.00 0.00% 1,818,792 $0.07 $0.07 $0.07
09 Feb 2021 $0.07 $0.00 0.00% 3,994,362 $0.07 $0.07 $0.07
08 Feb 2021 $0.07 $0.00 0.00% 868,514 $0.07 $0.07 $0.07
05 Feb 2021 $0.07 $0.00 0.00% 2,523,091 $0.07 $0.07 $0.07
04 Feb 2021 $0.07 $0.00 0.00% 1,876,754 $0.07 $0.07 $0.07
03 Feb 2021 $0.07 $0.00 0.00% 1,225,748 $0.07 $0.07 $0.07
02 Feb 2021 $0.07 $0.00 0.00% 2,367,349 $0.07 $0.07 $0.07
01 Feb 2021 $0.07 $0.00 0.00% 3,180,631 $0.07 $0.07 $0.07
29 Jan 2021 $0.07 $-0.01 -12.82% 12,267,882 $0.08 $0.08 $0.07
28 Jan 2021 $0.08 $0.00 0.00% 1,192,179 $0.08 $0.08 $0.08
27 Jan 2021 $0.08 $0.00 0.00% 974,184 $0.08 $0.08 $0.08
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Dec 2020 Michael Stein Issued 500 $45,000
02 Jul 2020 Anthony (Tony) Keating Sell 10 $1,500,000
01 Jul 2020 Anthony (Tony) Keating Exercise 20 $1,375,000
01 Jul 2020 Anthony (Tony) Keating Buy 20 $1,375,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Roger Aston Non-Executive Chairman,Non-Executive Director Jul 2015
Dr Michael Stein Non-Executive Director Apr 2020
Mr Christopher Ntoumenopoulos Non-Executive Director Jan 2015
Dr Anthony (Tony) Keating Chief Executive Officer,Managing Director Jul 2015
Mr Stephen John Hewitt-Dutton Joint Company Secretary Dec 2020
Ms Nicki Farley Company Secretary
Nicki Farley Company Secretary
Stephen John Hewitt-Dutton Joint Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 69,891,549 9.26%
Freeman Road Pty Ltd 40,500,000 5.36%
J P Morgan Nominees Australia Pty Limited 17,600,530 2.33%
Bnp Paribas Nominees Pty Ltd 17,266,887 2.29%
Mr Frank Weng Thong Chew 13,168,000 1.74%
Mr Anthony James Keating 10,000,000 1.32%
Equimetrixs Pty Ltd 8,437,500 1.12%
Narhex Life Sciences Developments Pty Ltd 7,997,005 1.06%
Cem International (Asia) Pty Ltd 7,849,888 1.04%
Mr Yongsheng Peng & Mrs Yuezhen Xie 4,798,502 0.64%
Let Superannuation Pty Ltd 4,444,103 0.59%
Citicorp Nominees Pty Limited 4,436,079 0.59%
Mr Victor John Wilk 4,400,000 0.58%
Mr Trent Antony Goodrick 4,000,000 0.53%
Wilk Holdings Pty Ltd 4,000,000 0.53%
Queensland Forest Industries Pty Ltd 3,806,830 0.50%
Gardmac Pty Ltd 3,681,395 0.49%
Mr Jason Dennis Roberts 3,431,954 0.45%
Dr Geoffrey Waring 3,303,764 0.44%
Sobol Capital Pty Ltd 3,109,375 0.41%
Show more